Related Experiment Video
Updated: Dec 18, 2025
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
33.9K
Non-opioid Analgesics and the Endocannabinoid System
Ruhan Deniz Topuz1, Özgur Gündüz1, Çetin Hakan Karadağ1
1Department of Medical Pharmacology, Trakya University School of Medicine, Edirne, Turkey
Balkan Medical Journal
|June 20, 2020
Summary
Non-opioid analgesics like paracetamol and dipyrone engage the endocannabinoid system for pain relief. They influence cannabinoid receptors and endocannabinoid levels through various mechanisms, distinct from traditional NSAIDs.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) primarily achieve pain relief via peripheral cyclooxygenase inhibition.
- Paracetamol and dipyrone, unlike classical NSAIDs, exhibit minimal anti-inflammatory effects, suggesting alternative antinociceptive pathways.
- These distinct analgesics are categorized as 'non-opioid analgesics'.
Purpose of the Study:
- To review and classify classical NSAIDs, paracetamol, and dipyrone as non-opioid analgesics.
- To elucidate the mechanisms by which the endocannabinoid system participates in the antinociceptive effects of these non-opioid analgesics.
Main Methods:
- Literature review focusing on the pharmacological mechanisms of non-opioid analgesics.
- Analysis of pathways involving the endocannabinoid system, including receptor activation and endocannabinoid level modulation.
- Examination of interactions with enzymes like fatty acid amide hydrolase (FAAH) and cyclooxygenase-2 (COX-2), and cellular uptake mechanisms.
Main Results:
- Non-opioid analgesics and their metabolites can activate cannabinoid receptors.
- These agents elevate endocannabinoid levels through multiple mechanisms: reduced degradation (FAAH/COX-2 inhibition), increased synthesis (COX inhibition), inhibited cellular uptake, and induced release.
- Inhibition of nitric oxide synthase production is also implicated in modulating endocannabinoid levels.
Conclusions:
- The endocannabinoid system is a key mediator of the antinociceptive effects of non-opioid analgesics.
- Diverse mechanisms contribute to the modulation of endocannabinoid signaling by non-opioid analgesics, highlighting a complex interplay.
- Understanding these interactions offers potential for novel pain management strategies targeting the endocannabinoid system.
Related Concept Videos
01:25Analgesia and Pain Management
1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
01:22Opioid Receptors: Overview
3.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.6K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
684
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
684
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
790
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
790
01:44Nociception
32.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
32.7K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
591
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
591